introduction, mission, history, production unit, animal health, Manufacturing science and technology, quality control, production planning, supply chain management, admin & IR
Macloeds Pharmaceuticals produces anti-tubercular and anti-histamine drugs at its facility in Baddi. Key production steps include tablet compression using rotary machines, tablet coating using fluidized bed coaters, and packaging through blister packing and strip packing. The training provided exposure to the industrial production environment and differences between practical and theoretical knowledge. [END SUMMARY]
Presentation tablet production madhu k sMadhu Honey
The document discusses the key equipment and processes used in tablet production, including size reduction equipment, mixers, granulators, dryers, tablet presses, and quality control equipment. It describes the main methods of tablet formulation as direct compression, dry granulation, and wet granulation. For wet granulation specifically, it outlines the steps of milling, weighing, mixing, wet massing using high-shear or fluid-bed granulators, drying granules, screening, lubricating, and compressing into tablets.
Nanosuspensions are colloidal dispersions of drug particles below 1 micron in size, stabilized by surfactants. They can improve the dissolution rate and bioavailability of poorly water soluble drugs compared to conventional formulations. The document discusses the definition, advantages, preparation techniques including high pressure homogenization and media milling, characterization, and applications of nanosuspensions through various routes of administration such as oral, intravenous, and ocular. Nanosuspensions reduce issues associated with poorly soluble drugs like low bioavailability and lack of dose proportionality.
This document provides information on quality management and quality control processes for pharmaceutical products. It discusses key concepts like quality assurance, quality control, quality management systems. It also summarizes the differences between quality assurance and quality control. The document then describes various quality control tests conducted on tablets and capsules, including tests of general appearance, hardness, friability, disintegration. It provides details on the purpose, procedures, and acceptance limits for these quality control tests.
The document discusses analytical quality by design (AQbD) and its implementation. It compares traditional analytical methods to AQbD methods. AQbD uses a systematic approach including risk assessment, design of experiments, and establishing a method operable design region. A case study demonstrates developing an HPLC method for assay using an AQbD approach including target measurement, design of experiment, method validation, and establishing a method operable design region. The conclusion states AQbD requires defining the right analytical target profile and using appropriate tools to ensure the right analytics are performed at the right time.
This document discusses tablet coating. It begins by providing a brief history of tablet coating and then discusses the reasons for coating tablets, including changing appearance, taste masking, and protecting ingredients from environmental conditions. It describes the three basic components of tablet coating: tablet properties, the coating process, and coating compositions. Under coating process, it discusses coating equipment types like conventional coating pans and fluidized bed coaters. It also covers coating parameters and types of coatings like sugar coating and film coating.
This document discusses common defects that can occur during the tablet coating process, including sticking and picking caused by overwetting, roughness from rapid drying of spray droplets, and orange peel effects from inadequate spreading of the coating solution. Other defects covered are bridging around tablet edges, filling of indentations, blistering from too rapid drying, hazing or dullness from high processing temperatures, color variation from improper mixing or ingredient migration, and cracking from internal stresses exceeding the film's tensile strength. Remedies for each defect aim to optimize the coating formulation, application process, or drying conditions.
This document discusses recent advancements in pharmaceutical tablet compression technology. It describes several types of tablet presses used for research and development as well as small-scale production, including single punch presses, rotary presses, bi-layer presses, and high-speed presses. It provides details on key features such as data acquisition capabilities, multi-layer tableting abilities, changeover times, and compliance with cGMP standards for several models. The document emphasizes that tablet output depends on factors like material properties, tablet specifications, and ambient conditions.
Macloeds Pharmaceuticals produces anti-tubercular and anti-histamine drugs at its facility in Baddi. Key production steps include tablet compression using rotary machines, tablet coating using fluidized bed coaters, and packaging through blister packing and strip packing. The training provided exposure to the industrial production environment and differences between practical and theoretical knowledge. [END SUMMARY]
Presentation tablet production madhu k sMadhu Honey
The document discusses the key equipment and processes used in tablet production, including size reduction equipment, mixers, granulators, dryers, tablet presses, and quality control equipment. It describes the main methods of tablet formulation as direct compression, dry granulation, and wet granulation. For wet granulation specifically, it outlines the steps of milling, weighing, mixing, wet massing using high-shear or fluid-bed granulators, drying granules, screening, lubricating, and compressing into tablets.
Nanosuspensions are colloidal dispersions of drug particles below 1 micron in size, stabilized by surfactants. They can improve the dissolution rate and bioavailability of poorly water soluble drugs compared to conventional formulations. The document discusses the definition, advantages, preparation techniques including high pressure homogenization and media milling, characterization, and applications of nanosuspensions through various routes of administration such as oral, intravenous, and ocular. Nanosuspensions reduce issues associated with poorly soluble drugs like low bioavailability and lack of dose proportionality.
This document provides information on quality management and quality control processes for pharmaceutical products. It discusses key concepts like quality assurance, quality control, quality management systems. It also summarizes the differences between quality assurance and quality control. The document then describes various quality control tests conducted on tablets and capsules, including tests of general appearance, hardness, friability, disintegration. It provides details on the purpose, procedures, and acceptance limits for these quality control tests.
The document discusses analytical quality by design (AQbD) and its implementation. It compares traditional analytical methods to AQbD methods. AQbD uses a systematic approach including risk assessment, design of experiments, and establishing a method operable design region. A case study demonstrates developing an HPLC method for assay using an AQbD approach including target measurement, design of experiment, method validation, and establishing a method operable design region. The conclusion states AQbD requires defining the right analytical target profile and using appropriate tools to ensure the right analytics are performed at the right time.
This document discusses tablet coating. It begins by providing a brief history of tablet coating and then discusses the reasons for coating tablets, including changing appearance, taste masking, and protecting ingredients from environmental conditions. It describes the three basic components of tablet coating: tablet properties, the coating process, and coating compositions. Under coating process, it discusses coating equipment types like conventional coating pans and fluidized bed coaters. It also covers coating parameters and types of coatings like sugar coating and film coating.
This document discusses common defects that can occur during the tablet coating process, including sticking and picking caused by overwetting, roughness from rapid drying of spray droplets, and orange peel effects from inadequate spreading of the coating solution. Other defects covered are bridging around tablet edges, filling of indentations, blistering from too rapid drying, hazing or dullness from high processing temperatures, color variation from improper mixing or ingredient migration, and cracking from internal stresses exceeding the film's tensile strength. Remedies for each defect aim to optimize the coating formulation, application process, or drying conditions.
This document discusses recent advancements in pharmaceutical tablet compression technology. It describes several types of tablet presses used for research and development as well as small-scale production, including single punch presses, rotary presses, bi-layer presses, and high-speed presses. It provides details on key features such as data acquisition capabilities, multi-layer tableting abilities, changeover times, and compliance with cGMP standards for several models. The document emphasizes that tablet output depends on factors like material properties, tablet specifications, and ambient conditions.
The document discusses quality control of parenteral products. It introduces parenterals and describes that they must be sterile, pyrogen-free, clear and stable. It outlines various quality control tests performed on parenterals like leaker tests, pyrogen tests and sterility tests. Leaker tests include visual inspection, dye tests and bubble tests to check for leaks. Pyrogen tests are conducted using in-vivo rabbit tests and in-vitro LAL tests. Sterility testing aims to detect microorganisms using direct inoculation of samples in fluid thioglycolate medium or soybean casein digest medium followed by incubation.
This document presents the development of nizatidine mucoadhesive microballoons for the treatment of peptic ulcers. Peptic ulcers occur in the stomach and duodenum due to an imbalance between aggressive and defensive factors. Nizatidine is an H2 receptor antagonist used to treat peptic ulcers. The objective is to develop microballoons to increase gastric residence time and bioavailability of nizatidine. Preformulation studies including solubility, compatibility and analytical method development were conducted. Microballoons will be formulated using different polymer combinations and evaluated for properties like mucoadhesion, drug release and stability. The formulation aims to localize nizatidine delivery and maintain therapeutic drug
This document discusses solid lipid nanoparticles (SLNs), including their definition as sub-micron colloidal carriers composed of physiological lipids. SLNs are spherical shaped with diameters between 10-1000 nm. They were designed to overcome issues with liquid lipid carriers. Methods for preparing SLNs include high pressure homogenization and ultrasonication. Characterization techniques involve determining particle size, zeta potential, and crystallinity. SLNs offer advantages like biocompatibility and protecting labile drugs, though drug loading capacity can be poor. Potential applications include cancer chemotherapy and targeted drug delivery.
This document provides information on coating equipment and the coating process for tablets. The objectives of coating are to protect tablets from stomach acid, protect the stomach lining from drugs, provide delayed release, and maintain tablet shape. The coating process involves tablets rotating in a drum and being coated with a liquid spray that is then dried. Parameters like temperature, spray rate, and coating thickness are monitored throughout the process. The document outlines acceptance criteria to ensure a smooth coating process without issues like temperature fluctuations or coating defects.
QUALITY CONTROL OF SOLID DOSAGE FORMS (TABLETS , CAPSULES & POWDERS)Hasnat Tariq
This document discusses quality control tests for solid dosage forms, specifically tablets. It describes common tests like hardness, thickness and diameter, friability, weight variation, and disintegration. Hardness tests the force required to break a tablet and can affect other properties. Thickness and diameter are important for specifications and uniform dosing. Friability tests the tablets' ability to withstand abrasion and breakage from handling. Weight variation ensures uniform tablet weights. Disintegration tests how long it takes a tablet to break down, which correlates to drug release. The document provides details on procedures, equipment, and specifications for each test.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
The document describes Juhi Sharma's internship report on her experience working in the Quality Control laboratories at IPCA Laboratories Ltd. in Kandla, India. It discusses her dedication to the internship and thanks her supervisors for their guidance. It provides details about IPCA Laboratories, including information about the company, its products, facilities, and quality control testing processes and equipment used.
The system to deliver the drug to the body to produced desired therapeutic action and activity against diseases and disorders is known as Drug delivery system
This document discusses the scale-up considerations for producing parenteral drugs on a pilot plant scale. It describes the key unit operations in parenteral production as mixing, sterilization, filtration, filling and sealing. For each unit operation, parameters that must be considered for scale-up are identified, such as tank size and type, impeller design, membrane size, filling rate and container size. Maintaining sterility and avoiding issues like precipitation or clogging are important challenges addressed during scale-up. Quality control tests are used to evaluate the scaled processes. Proper scale-up allows efficient transition from laboratory to commercial production of injectable drug products.
This document summarizes the standards and testing methods for different types of tablets according to the Indian Pharmacopoeia. It describes 10 types of tablets and the standards that apply to all tablets, including content uniformity, weight variation, disintegration, friability, and dissolution testing. The document provides details on the acceptance criteria and testing procedures for each of these standards.
The document discusses drug degradation and stability. It defines drug degradation as the chemical breakdown of drug molecules through collisions, affected by factors like oxygen, moisture, acidity, alkalinity and light. Degradation pathways include hydrolysis, oxidation, photolysis, and racemization. More processed and formulated drugs degrade faster than pure drugs due to the presence of excipients and processing. Common routes of chemical degradation are solvolysis, oxidation, dehydration, optical isomerization, and hydrolysis. Physical degradation involves changes in state like polymorphism, vaporization, and absorption or loss of water. Microbial contamination can also cause drug breakdown. Proper storage, packaging, and use of preservatives can help prevent
1) The document discusses different types of mixers used for batch and continuous mixing in pharmaceutical manufacturing.
2) It describes various impellers like propellers, turbines, and paddles used for liquid batch mixing and semi-solid mixers like sigma blade and planetary mixers.
3) The document also covers continuous mixers like baffled pipes and different jet mixers used for liquid mixing as well as roller mills for semi-solid mixing.
Warm Greetings from Chempro Pharma! Here is a brief presentation regarding our newest project/service offering - pharmaceutical product development. We have a highly specialized team that has worked with the likes of Novartis, Merck and many more market leaders within the pharmaceutical industry. Feel free to review this attachment and contact us at pharma@chemprogroup.net if you have any questions, thanks!
$ CONTENTS $
#Introduction
#Objective of granulation
#Essential properties of granules
#Mechanism of bond formation
#Mechanism of granule formation
#Method of granulation
#Modern equipments in granulation technology
The document describes the operation and validation of an industrial double door autoclave. It provides details on the various sterilization cycles used - vacuum leak test, Bowie-Dick test, steam in process test, gravity cycle, and high pressure high vacuum cycle. The procedures, parameters, and results of running these cycles to validate the autoclave are presented. The conclusion is that the autoclave satisfies all United States Pharmacopeia parameters and can be used for sterilization.
This document discusses nanoparticles for drug delivery. It begins with an introduction to nanoparticles and their goals in drug delivery. It then describes different types of nanoparticles including solid lipid nanoparticles (SLNs) and polymeric nanoparticles. The document provides details on the composition, size and applications of SLNs and polymeric nanoparticles. It discusses methods for preparing SLNs and polymeric nanoparticles and provides examples of their use in cancer therapy, vaccines, and other therapeutic applications.
1. Preformulation testing involves characterizing key properties of drugs and excipients to develop safe, effective, and stable dosage forms. Tests include analyzing organoleptic properties, purity, solubility, hygroscopicity, and compatibility.
2. Analytical methods are important to quantify drugs during product development and stability testing. UV and HPLC methods are often used depending on the drug's chromophores.
3. Solubility studies over the pH range of 1-8 are crucial because permeability and absorption depend on a drug's ionization state and solubility in different regions of the gastrointestinal tract.
The document describes the trainees' in-plant training report submitted to Beximco Pharmaceuticals Ltd, thanking the company for the opportunity and providing an overview of the aims and objectives of their training, as well as summaries of their experiences in each department.
Niosomes are novel drug delivery systems where medication is encapsulated in a non-ionic surfactant-based vesicle. They are similar to liposomes but are made of surfactant bilayers instead of phospholipid bilayers. Niosomes can be prepared in different sizes and methods to encapsulate both hydrophilic and hydrophobic drugs. They provide advantages over liposomes such as being more stable and having less variability. Niosomes show potential for targeted drug delivery and increasing drug bioavailability.
This document discusses the use of thermal analysis techniques like differential thermal analysis (DTA), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA) in preformulation studies. These techniques are used to characterize properties of drug substances and excipients like polymorphism, degree of crystallinity, moisture content, and thermal stability. They provide important information on aspects like purity, solid-solid interactions, and decomposition behavior which helps optimize dosage form development. The principles and applications of DTA, DSC, and TGA are explained to analyze various thermal events in materials.
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
The document provides an orientation report on Novartis International, covering its history, operations, and key areas. Some key points:
- Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz Laboratories. It is now the second largest pharmaceutical company globally.
- It produces many major drugs and owns Sandoz, a large generic drug manufacturer.
- Ciba-Geigy and Sandoz both had long independent histories as Swiss chemical and pharmaceutical companies before merging to form Novartis.
- The report outlines Novartis' operations including quality assurance, research and development, manufacturing areas, and engineering. It provides details on specific production processes and quality testing
The document discusses quality control of parenteral products. It introduces parenterals and describes that they must be sterile, pyrogen-free, clear and stable. It outlines various quality control tests performed on parenterals like leaker tests, pyrogen tests and sterility tests. Leaker tests include visual inspection, dye tests and bubble tests to check for leaks. Pyrogen tests are conducted using in-vivo rabbit tests and in-vitro LAL tests. Sterility testing aims to detect microorganisms using direct inoculation of samples in fluid thioglycolate medium or soybean casein digest medium followed by incubation.
This document presents the development of nizatidine mucoadhesive microballoons for the treatment of peptic ulcers. Peptic ulcers occur in the stomach and duodenum due to an imbalance between aggressive and defensive factors. Nizatidine is an H2 receptor antagonist used to treat peptic ulcers. The objective is to develop microballoons to increase gastric residence time and bioavailability of nizatidine. Preformulation studies including solubility, compatibility and analytical method development were conducted. Microballoons will be formulated using different polymer combinations and evaluated for properties like mucoadhesion, drug release and stability. The formulation aims to localize nizatidine delivery and maintain therapeutic drug
This document discusses solid lipid nanoparticles (SLNs), including their definition as sub-micron colloidal carriers composed of physiological lipids. SLNs are spherical shaped with diameters between 10-1000 nm. They were designed to overcome issues with liquid lipid carriers. Methods for preparing SLNs include high pressure homogenization and ultrasonication. Characterization techniques involve determining particle size, zeta potential, and crystallinity. SLNs offer advantages like biocompatibility and protecting labile drugs, though drug loading capacity can be poor. Potential applications include cancer chemotherapy and targeted drug delivery.
This document provides information on coating equipment and the coating process for tablets. The objectives of coating are to protect tablets from stomach acid, protect the stomach lining from drugs, provide delayed release, and maintain tablet shape. The coating process involves tablets rotating in a drum and being coated with a liquid spray that is then dried. Parameters like temperature, spray rate, and coating thickness are monitored throughout the process. The document outlines acceptance criteria to ensure a smooth coating process without issues like temperature fluctuations or coating defects.
QUALITY CONTROL OF SOLID DOSAGE FORMS (TABLETS , CAPSULES & POWDERS)Hasnat Tariq
This document discusses quality control tests for solid dosage forms, specifically tablets. It describes common tests like hardness, thickness and diameter, friability, weight variation, and disintegration. Hardness tests the force required to break a tablet and can affect other properties. Thickness and diameter are important for specifications and uniform dosing. Friability tests the tablets' ability to withstand abrasion and breakage from handling. Weight variation ensures uniform tablet weights. Disintegration tests how long it takes a tablet to break down, which correlates to drug release. The document provides details on procedures, equipment, and specifications for each test.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
The document describes Juhi Sharma's internship report on her experience working in the Quality Control laboratories at IPCA Laboratories Ltd. in Kandla, India. It discusses her dedication to the internship and thanks her supervisors for their guidance. It provides details about IPCA Laboratories, including information about the company, its products, facilities, and quality control testing processes and equipment used.
The system to deliver the drug to the body to produced desired therapeutic action and activity against diseases and disorders is known as Drug delivery system
This document discusses the scale-up considerations for producing parenteral drugs on a pilot plant scale. It describes the key unit operations in parenteral production as mixing, sterilization, filtration, filling and sealing. For each unit operation, parameters that must be considered for scale-up are identified, such as tank size and type, impeller design, membrane size, filling rate and container size. Maintaining sterility and avoiding issues like precipitation or clogging are important challenges addressed during scale-up. Quality control tests are used to evaluate the scaled processes. Proper scale-up allows efficient transition from laboratory to commercial production of injectable drug products.
This document summarizes the standards and testing methods for different types of tablets according to the Indian Pharmacopoeia. It describes 10 types of tablets and the standards that apply to all tablets, including content uniformity, weight variation, disintegration, friability, and dissolution testing. The document provides details on the acceptance criteria and testing procedures for each of these standards.
The document discusses drug degradation and stability. It defines drug degradation as the chemical breakdown of drug molecules through collisions, affected by factors like oxygen, moisture, acidity, alkalinity and light. Degradation pathways include hydrolysis, oxidation, photolysis, and racemization. More processed and formulated drugs degrade faster than pure drugs due to the presence of excipients and processing. Common routes of chemical degradation are solvolysis, oxidation, dehydration, optical isomerization, and hydrolysis. Physical degradation involves changes in state like polymorphism, vaporization, and absorption or loss of water. Microbial contamination can also cause drug breakdown. Proper storage, packaging, and use of preservatives can help prevent
1) The document discusses different types of mixers used for batch and continuous mixing in pharmaceutical manufacturing.
2) It describes various impellers like propellers, turbines, and paddles used for liquid batch mixing and semi-solid mixers like sigma blade and planetary mixers.
3) The document also covers continuous mixers like baffled pipes and different jet mixers used for liquid mixing as well as roller mills for semi-solid mixing.
Warm Greetings from Chempro Pharma! Here is a brief presentation regarding our newest project/service offering - pharmaceutical product development. We have a highly specialized team that has worked with the likes of Novartis, Merck and many more market leaders within the pharmaceutical industry. Feel free to review this attachment and contact us at pharma@chemprogroup.net if you have any questions, thanks!
$ CONTENTS $
#Introduction
#Objective of granulation
#Essential properties of granules
#Mechanism of bond formation
#Mechanism of granule formation
#Method of granulation
#Modern equipments in granulation technology
The document describes the operation and validation of an industrial double door autoclave. It provides details on the various sterilization cycles used - vacuum leak test, Bowie-Dick test, steam in process test, gravity cycle, and high pressure high vacuum cycle. The procedures, parameters, and results of running these cycles to validate the autoclave are presented. The conclusion is that the autoclave satisfies all United States Pharmacopeia parameters and can be used for sterilization.
This document discusses nanoparticles for drug delivery. It begins with an introduction to nanoparticles and their goals in drug delivery. It then describes different types of nanoparticles including solid lipid nanoparticles (SLNs) and polymeric nanoparticles. The document provides details on the composition, size and applications of SLNs and polymeric nanoparticles. It discusses methods for preparing SLNs and polymeric nanoparticles and provides examples of their use in cancer therapy, vaccines, and other therapeutic applications.
1. Preformulation testing involves characterizing key properties of drugs and excipients to develop safe, effective, and stable dosage forms. Tests include analyzing organoleptic properties, purity, solubility, hygroscopicity, and compatibility.
2. Analytical methods are important to quantify drugs during product development and stability testing. UV and HPLC methods are often used depending on the drug's chromophores.
3. Solubility studies over the pH range of 1-8 are crucial because permeability and absorption depend on a drug's ionization state and solubility in different regions of the gastrointestinal tract.
The document describes the trainees' in-plant training report submitted to Beximco Pharmaceuticals Ltd, thanking the company for the opportunity and providing an overview of the aims and objectives of their training, as well as summaries of their experiences in each department.
Niosomes are novel drug delivery systems where medication is encapsulated in a non-ionic surfactant-based vesicle. They are similar to liposomes but are made of surfactant bilayers instead of phospholipid bilayers. Niosomes can be prepared in different sizes and methods to encapsulate both hydrophilic and hydrophobic drugs. They provide advantages over liposomes such as being more stable and having less variability. Niosomes show potential for targeted drug delivery and increasing drug bioavailability.
This document discusses the use of thermal analysis techniques like differential thermal analysis (DTA), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA) in preformulation studies. These techniques are used to characterize properties of drug substances and excipients like polymorphism, degree of crystallinity, moisture content, and thermal stability. They provide important information on aspects like purity, solid-solid interactions, and decomposition behavior which helps optimize dosage form development. The principles and applications of DTA, DSC, and TGA are explained to analyze various thermal events in materials.
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
The document provides an orientation report on Novartis International, covering its history, operations, and key areas. Some key points:
- Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz Laboratories. It is now the second largest pharmaceutical company globally.
- It produces many major drugs and owns Sandoz, a large generic drug manufacturer.
- Ciba-Geigy and Sandoz both had long independent histories as Swiss chemical and pharmaceutical companies before merging to form Novartis.
- The report outlines Novartis' operations including quality assurance, research and development, manufacturing areas, and engineering. It provides details on specific production processes and quality testing
EPCIS Event-Based Traceability in Pharmaceutical Supply Chains via Automated ...Monika Solanki
The document discusses enabling traceability in pharmaceutical supply chains through automated generation of linked pedigrees from EPCIS event data. It proposes using ontologies like EEM and CBVVocab to model EPCIS events and define pedigrees as subsets of related events. An algorithm is described that could generate linked pedigrees by analyzing streams of serialized EPCIS events to extract relevant events and assemble pedigrees representing the movement of products through the supply chain. The approach aims to improve visibility and counterfeit detection in pharmaceutical supply chains using semantic web technologies.
Definition, History, Notes in perfume, Classification of perfume, Aromatic sources, Manufacturing, Ingredients causing allergic reactions, attar, types of attar, difference between attar and perfume, reasons behind using perfume, leading brands of perfume.
The document provides an overview of perfume, including its history, composition, and methods of description. It discusses how perfume has been used since ancient times to enhance scents. It also outlines the main components of perfumes, concentration levels, olfactive families that perfumes can belong to, and how notes are used to describe a perfume's scent over time.
Cosmetics and perfumes have been used for thousands of years to enhance beauty and provide pleasant smells. Perfume is created by combining fragrant essential oils, aroma compounds, and solvents. Ancient Egyptians were among the first cultures to incorporate perfumes, which were made from plant parts like bark, flowers, fruits, leaves, resins, roots, and woods, as well as substances like ambergris, castoreum, civet, hyraceum, and honeycomb. Common fragrance compounds include calone, linalool, coumarin, and white musk, while solvents include acetone, benzaldehyde, benzyl acetate, benzyl alcohol, camphor, ethanol, and
The document provides statistics on the global and US perfume industries. Some key details include:
- The annual global perfume industry sales revenue is $27.5 billion, while the US market is $5.2 billion.
- In 2002, there were 756 perfume brands in US department stores.
- Only 1% of celebrity perfume brands are priced over $75, compared to 46% of designer perfume brands.
- 87% of American women use perfume.
- Coty Inc holds 13% of the fragrance market share.
IN-PLANT TRAINING REPORT (Ali asraf sohel)ASRAF SOHEL
The document provides an overview of Ali Asraf Sohel's in-plant training report at ACME Laboratories Ltd. It describes his visits to various departments including warehouse, production, quality assurance, quality control, and engineering. The key departments and their functions are summarized. The production process for different drug formulations like tablets, capsules, syrups, and injections are outlined. Analytical testing procedures for raw materials, packaging materials and finished products are also highlighted.
The document provides an overview of Ali Asraf Sohel's in-plant training report at ACME Laboratories Ltd. It describes his visits to various departments including warehouse, production, quality assurance, quality control, and engineering. The key departments and their functions are summarized. The production process for different drug formulations like tablets, capsules, syrups, and injections are outlined. Analytical testing procedures for raw materials, packaging materials and finished products are also highlighted.
Shandong Sunnygrain Bioengineering Co., Ltd. is a Chinese company that produces natural vitamin E, phytosterols, and fatty acid methyl esters. It has over 150 employees, operates out of Shandong province, and has several international certifications. The company has an R&D center and produces over 600 tons per year of various natural vitamin E and phytosterol products that it markets globally, with over half of sales going to North America.
This industrial training report describes Tapasya Pal's one month training at Navkar Lifesciences. The report includes sections on the manufacturing, packaging, and testing processes at the facility. It provides details on the equipment used in granulation, blending, compression, and coating of pharmaceutical products. It also discusses packaging methods like ALU-ALU packing, blister packing, and strip packing. Maintaining good manufacturing practices and standard operating procedures is emphasized.
Longfian Scitech Co., Ltd is a manufacturer of medical oxygen concentrators located in China. They have established factories in Baoding, Hebei Province and Dongguan, Guangdong Province. The company has an R&D team that can independently develop the hardware and software for oxygen concentrators. They produce a range of oxygen concentrators from 1LPM to 60LPM that are used in various settings like homes, hospitals, clinics, and high altitude areas. The company aims to provide reliable, high quality oxygen concentrator and oxygen-related products to over 160 countries.
The document summarizes Arifa Jabeen Memon's 40-day training report at Novartis Pharma OTC in Jamshoro, Pakistan from January to February 2014. It includes information about Novartis' history and departments observed during the training, such as production, quality assurance, and warehousing. Standard operating procedures, production processes like granulation and compression, and quality control measures are also outlined.
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry PrakashKumar721
Location:- GIDC Estate Ankleswar
393002, Dist. Bharuch ,Gujrat India
Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better supportpeople’s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.
About Zentiva’s Ankleshwar site
Established in 1987, the Ankleshwar manufacturing site has a chemistry and biotechnology development center, and manufactures both intermediates and pharmaceutical formulations. A large producer of tablets, the Ankleshwar site manufactures more than 6 billion tablets annually.
Mission &Values:-
Zentiva is a leading developer and supplier of high-quality affordable prescription medicines and consumer brands. As Zentiva grows more people get the medicine they need. Our business is built on trust and responsibility with the patient at the heart of everything we do. Zentiva has established 6 shared SuperpowerZ which frame the values and behaviours we expect of our team and how we will build a healthy business that we can all be proud of.
TABLET-SECTION
Tablet:-
A tablet is a mixture of active substances and excipients, usually in powder form, pressed or compacted into a solid. The excipients include binders, Glidants (flow aids) and lubricants to ensure efficient tabletting, disintegrates to ensure that the tablet breaks up in the digestive tract; sweeteners or flavors to mask the taste of bad-tasting active ingredients; and pigments to make uncoated tablets visually attractive. A coating may be applied to hide the taste of the tablet's components, to make the tablet smoother and easier to swallow, and to make it more resistant to the environment, extending its shelf life.
Advantage
• Production aspect
Large scale production at lowest cost
Easiest and cheapest to package and ship
High stability
• User aspect (doctor, pharmacist, patient)
Easy to handling.
Lightest and most compact.
Greatest dose precision & least content variability.
Coating can mark unpleasant tastes & improve pt. acceptability.
PHARMACEUTICAL PRODUCT BY ZENTIVA PHARMACEUTICAL PVT.LTD:-
1. Avil -25 mg
2. Trental-400
3. Paracetamol-500mg
4. Ramilich-( 5, 25mg)
5. Ramipril-25mg
6. Zuglimate-500mg
7. Clopidogrel-75mg
8. Metformin-100mg
QUALITY CONTROL AND QUALITY ASSUARANCE
Quality control is the part of GMP that deals with sampling, specification, and testing, as well as organisation, documentation, and release procedures to ensure that necessary and
The document summarizes Supriya Kumari's one month industrial training report at NAVKAR LIFESCIENCE Pvt. Ltd. It includes an overview of the company and its vision, sections within the pharmaceutical plant including tablet, capsule and oral liquid production, and quality control processes. Key areas covered are tablet manufacturing involving granulation, compression and coating, capsule filling, and quality control equipment used to test raw materials and finished products. The report provides insights into various unit operations and aims to fulfill the requirements for Supriya's B.Pharma degree.
Ipca Laboratories is an Indian pharmaceutical company established in 1949 that exports medications to over 100 countries. The company aims to become a $400 million company by 2010 by expanding its global leadership in antimalarial drugs and key partnerships. Ipca has over 4,500 employees and facilities in Athal, Ratlam, and Kandla for manufacturing tablets, capsules, liquids, and injectables. It has regulatory approvals from agencies in the UK, Australia, South Africa, Brazil, and WHO. Research and development is a priority, with over $5 million annually spent on developing generic drugs and new drug delivery systems through collaborations with Indian universities.
Penn Pharma provides pharmaceutical development, manufacturing, packaging, and consulting services. Their capabilities include formulation development, analytical testing, clinical trial supply, commercial manufacturing, and QP certification. They have facilities for tablets, capsules, liquids, and other dosage forms. Penn Pharma offers a full range of integrated services to support customers from pre-clinical development through commercialization.
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy
Medipolis GMP is a Finnish CMO specialized in microbial fermentation, cell culture, and monoclonal antibody production. They offer process development and cGMP manufacturing services from gene to clinical phases. Their 23,000 square foot facility meets EMEA requirements and has fermentation, purification, and analytical equipment to support projects up to clinical phase II trials. Medipolis aims to help customers efficiently develop and manufacture biopharmaceuticals.
Appreciated by customers across the nation for supplying, trading and wholesaling a broad array of high quality pharmaceutical hygiene & cleanRoom
products, June Enterprises started its operations in December 2013.
In a short span of time, the company expanded its breadth of operations to provide CleanRoom Products to the Indian pharmaceutical industry &
neighboring countries.
The product range offered by June Enterprises includes: – Sterilization Monitoring & Validation Products, ATCC Culture, Cleanroom Garments &
Accessories, Cleanroom Supplies, Critical Cleaning Products, Products for Food & Facilities, Sterilization Packaging & Sealing Products, Products for
Stores & Warehouses, USP Class Silicone Tubing among others.
In order to ensure high standards of quality, the offered range of Cleanroom Products is procured and sourced from trusted and reliable Leaders in their
® ® respective product ranges for example Sterilization Products by Mesa Labs, Cleaning & disinfectants by Contec & ATCC by Microbiologics.
With years of experience, expertise and a proven track-record of helping many companies with its CleanRoom Products & Sterilization needs, June
Enterprises has established an enviable position in the PHARMA, FOOD & HOSPITAL segments.
JUNE Enterprises is an ISO 9001:2015 certified company.
Learn More: https://www.juneenterprises.com/
Danadams Pharmaceutical is a Ghanaian pharmaceutical company established in 2005 with over 250 employees. It produces antiretroviral and other pharmaceutical drugs, and was adjudged the top healthcare leader in Ghana in 2010. The company's vision is to create a healthy Africa through innovative, high quality products. This presentation discusses Danadams' manufacturing process for Danmether tablets, an antimalarial drug. The process involves raw material receipt and testing, granulation, compression, quality control testing, packaging and labeling, and storage of finished goods. Danadams is committed to complying with cGMP guidelines to ensure product quality and safety.
The document discusses the layout, equipment, and processes required for the production of solid oral dosage forms like tablets in a pharmaceutical manufacturing facility. It provides details on the building facilities, various production areas and equipment for activities such as granulation, drying, milling, blending, compression, coating, packaging and quality control tests. The layout is designed for proper material and air flow following cGMP guidelines. Commonly used equipment for different processes are also outlined.
This document discusses scaling up solid dosage forms from the laboratory to production scale. It defines scale up as transforming a lab scale formula into a viable product through developing reliable manufacturing procedures. The goals of pilot plant studies are to produce stable dosage forms, identify critical process features, provide manufacturing specifications, and guide commercial production. Various granulation methods - wet, dry, and fluidized - and equipment used at different scales are described. Challenges like ensuring homogenous mixing and particle size control across scales must be addressed during scale up studies to reliably manufacture products.
This document provides an overview of Aditya Flexipack Ltd., an Indian flexible packaging company. It summarizes the company's growth path from establishing its first unit in 2000 to now operating four manufacturing plants with a total annual production capacity of 35,400 tonnes per year. The company's vision, mission, and core values focus on customer satisfaction, sustainability, and innovation. The document also outlines the company's manufacturing infrastructure, quality certifications, sustainability efforts, awards received, client list of major brands, and competitive advantages in the flexible packaging industry.
This document provides an overview of Aditya Flexipack Ltd., an Indian flexible packaging company. It summarizes the company's growth path from establishing its first unit in 2000 to now operating four manufacturing plants with a total annual production capacity of 35,400 tonnes per year. The company's vision, mission, and core values focus on customer satisfaction, sustainability, and innovation. The document also outlines the company's manufacturing infrastructure, quality certifications, sustainability efforts, awards, client list, and competitive advantages.
Abhishek Ghara completed an industrial training at Gluconate Health Limited, a pharmaceutical manufacturing company in West Bengal.
[1] The company was formed through the merger of two companies in 1990 and is wholly owned by the government of West Bengal.
[2] Ghara thanks the managers and staff at the company for their cooperation and guidance during his training.
[3] He provides details of the company's production, quality control, packaging, and other departments as well as the instruments used and manufacturing processes for tablets, capsules, and liquids.
Aarti Pharmalabs Ltd specializes in the clinical phase and commercial production of APIs and NCEs, intermediates, regulatory starting materials, key building blocks and xanthine derivatives. Our offerings include process R&D, analytical method development and validations, stability studies, scale-up and process optimization, process validations and commercial production. The quality and purity of our products have enabled us to be the leading Active Pharmaceutical ingredients manufacturers in India.
Similar to Novartis industrial training overview (20)
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Gender and Mental Health - Counselling and Family Therapy Applications and In...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
4. Mission of Novartis
• We want to discover, develop and successfully market innovative products
to cure diseases, to ease suffering, and to enhance the quality of life. We
also want to provide a shareholder return that reflects outstanding
performance and to adequately reward those who invest ideas and work
in our company.
• We want to be recognized for having a positive impact on people's lives
with our products, meeting needs and even surpassing external
expectations.
• We want to contribute to society through our economic contribution,
through the positive environmental and social benefits of our products,
and through open dialogue with our stakeholders.
5. Production Department (Plant A)
Units of the production department are:
1. DISPENSING UNIT
2. GRANULATION UNIT
3. COMPRESSION UNIT
4. COATING UNIT
5. ENCAPSULATION UNIT
6. PACKAGING UNIT - primary & secondary
6. Dispensing Unit
The dispensing unit is divided into thee areas:
Dispensing unit A
Dispensing unit A1
Dispensing unit B
Major functions of dispensing unit are:
• To prevent cross contamination
• Weighing of materials (excipients first, then API)
• To reduce operator’s exposure to powder
• To receive materials from warehouse as per DOS
• Attachment of dispensing label on each dispensed container
7. Machines in Dispensing Unit
• Weighing machine:
Mettler: toledo(34 kg)
Mettler: IDS, T-2000 (0.4-240kg)
Made in Switzerland
• Standard calibration weight:
Mettler (Switzerland)
• Air exhaust system
• Water supply system:
Hot, normal & de-ionized water
Mettler Weighing Machines
8. Granulation Unit
The granulation unit is divided into four areas:
Granulation area A
Granulation area A1
Granulation area A2
Granulation area A3
Purpose:
• To prevent dust contamination by maintaining negative pressure in the granulation area
• To prevent segregation of constituents in the powder mix
• To improve flow properties of powder
• To improve compression nature of powder
9. Machines in Granulation Area
• Granulator:
T.K Fielder(German), Yenchen (Taiwan)
• FBD:
Aeromatic(Swiss), Yenchen(Taiwan),
Solace(India)
• Milling machine:
Fitz Mill (German), Multi Mill (India)
• Grinding machine:
Frewitt (Swiss)
• Final Blending Device:
LLB final blending machine, Double cone mixer
(India), LLB final blending machine
Drum mixer
• Stainless steel container
Bhole container (German),
Artofex container (Swiss) Yenchen granulator and fluid bed dryer
10. Compression Unit
When the granulation is done the final granules are stored in a container and then it is
delivered to the compression unit for compression. It is also divided into three units
named A, A1 & B.
Parameters to be checked:
• Proper cleaning of machine.
• Proper arrangement of the die and punch.
• Removal of all the materials relevant to previous product.
• HVAC system.
• Humidity.
• Temperature.
• Pressure differential during pre-compression and compression phase.
12. Coating Unit
A layer of polymer or sugar is applied on the core of the tablet. Some coating materials are:
Sugar, acrylic polymer, methacrylic acid polymer, cellulose derivatives, ethyl acetate etc.
Purpose:
• Avoid inactivation of drug in the stomach
• Mask bad taste
• Improve dosing interval
• Reduce influence of moisture and atmosphere
• Improve appearance and acceptability
• Increase market appeal
• Attracting pediatric and younger patients
14. Encapsulation
Capsules are solid dosage forms in which the drug substance is enclosed in a hard / soft gelatin,
soluble container or shell of a suitable form of gelatin.
Capsules are of two types:
•Hard gelatin capsule
•Soft gelatin capsule
Machines available in Encapsulation Unit:
Machine: BOSCH (German)
Channel: Single
CPM: 300
CPH: 18,000
Output: 36 (per rotation)
Balance: Mettler PM2000
Maximum: 2 kg
Minimum: Not defined.
BOSCH Encapsulation
15. Packaging
Purpose:
• To increase stability of the drug
• To increase the acceptability of the drug
• To minimize the transport hazard
• To improve patient compliance
Packaging can be divided into three ways:
i. Primary packaging
ii. Secondary packaging
iii. Tertiary packaging
16. Primary Packaging
Three types:
Blister packaging
Strip packaging
Bottle filling & sealing
Machines used for the Primary Blister Packaging:
CAM1
CAM 2
Ottohansel(manual)
Uhlmann
Printing machine:
HAPAmatic (Swiss) CAM automatic blister packaging
17. Secondary Packaging
Secondary Packaging Materials:
Plastics
Paper containers and cartons
The labeling contains the following Information:
Batch No.
Manufacturing Date
Expiry date
18. Popular Products Of Novartis Bangladesh Ltd.
Brand Name Generic Pack Size Price(MRP)
AZYTH 500 Azithromycin 500mg x10’s 300.00
SETIC Cefixime 200mg x 14’s 420.00
SERVIFLOX Ciprofloxacin 250mg x 30’s 242.70
RIMSTAR 4-FDC Rifampicin+Isoniazid+Pyrazinamide
+Ethambutol
900mg x 50’s 376.50
PROBITOR Omeprazole 20mg x 60’s 420.00
VOLTALIN Diclofenac 25mg x100’s 305.00
BINOCLAR Clarithromycin 250/500mg x 40’s 495.60
SANDOCAL-D Calcium+Vitamin D 500mg x 50’s 350.00
CALCIUM SANDOZ Calcium Carbonate 250mg x 50’s 175.00
TEGRETOL Carbamazipine 200mg x 50’s 326.50
19. Production Department (Plant C)
The Animal Health business unit in Bangladesh is dedicated to maintaining and improving the health of
farm animal since 1977.
Production Facilities:
• Dispensing Unit
• Granulation Unit
Machines:
Double cone blender
Multimill
FBD
Planetary mixer
• Compression Unit
• Sachet filling Unit
• Packaging Unit
20. Popular Animal Health Products of Novartis
Name Generic Name Pack Size Product Type
Digitop Ammonium
bicarbonate, nux
vomica
20x20 Pack Dairy
Fasinex Triclabendazole 10x4 Dairy
Ralinex levamisol 10x4 Dairy
Geotox Mineral oxides 25 kg Aqua
Chlorsteclin Chlortetracycline 1kg Poultry
Cinoflox Enrofloxacin HCl 10x100 Poultry
Coxiclin Diclazuril 25 kg Poultry
21. QUALITY ASSURANCE DEPARTMENT
Quality Assurance/ QA Department is divided into two major categories:
i. Quality Compliance
ii. Quality Control.
Quality Compliance:
In Novartis (Bangladesh) Limited, Quality compliance department use
mainly SAP software. External or Global audit is performed after every 2
years by the officials of
1.EU
2.MCC (South Africa)
3.ANVISA (Brazil)
Internal audit or internal self inspection is performed 2 times in a year.
At present five people are working in Quality compliance.
22. In Process Quality Control
• The main function of IPQC is to give line clearance in every steps of
production like dispensing, granulation, compression, coating and packaging.
• It also ensures proper cleaning of the machine and production area after
each batch.
Line clearance is given after following functions:
• Clearance
• Cleaning
• Inspection by operator
• Verification by IPQC using specific guidelines of GMP
23. QUALITY CONTROL
According to GMP Quality control can be defined broadly as the regular
control of quality ensured by pharmacist and technicians responsible for
the acceptance or rejection of incoming raw materials and packaging
components.
According to the function, Q.C is divided into three parts.
They are :
1.FDF analysis section
2.Logistic Department
3.Microbiological section
24. Instruments In QC Lab
NO. Instrument Manufacturer
1 Digital Ultrasonic Bath Power Sonic 520
2 Milli-Q Water System Quantum Ex, Gra
3 Digital Shaker G.F.L
4 Digital Centrifuge Machine BOECO(Germany)
5 Disintegration Tester DT2
6 Vacuum Dryer Salvis
7 Muffle Furnace Carbolite
8 Dissolution Apparatus 3 Electrolab
9 Dissolution Apparatus 1,5,6(USP 4) Sotax
10 pH meter Seven Compact
25. Instruments In QC Lab
NO. Instrument Manufacturer
11 UV spectrometer Spectronic UNICAM UV
12 Digital Polarimeter Anton Paov
13 Gas Chromatography Agilent 7890A
14 TOC Analyzer Shimadzu
15 HPLC System 1 Agilent 1260
16 HPLC System 2 Shimadzu Prominence Single
Pump
17 HPLC System 3 Shimadzu 1500
18 HPLC System 4 Agilent 1100
19 HPLC System 5 Dionex UH 3000
20 HPLC System 6 Dionex Ultimate 3000
27. Manufacturing Science and Technology Department
MS&T department is divided into five units, they are:
1.Galenical Development Unit
2.Analytical Development Unit
3.Product Migration Unit
4.Plant Machineries Unit
5.Packaging Product
Objectives:
• Develop BMR that ensures smooth production
• Development of better quality products
• Discover ways of cost effectiveness
• Technology transfer
28. Instruments in MS&T Department
Instruments name Manufacturer name Country
Fluid bed dryer (1 piece) Solace India
Planetary Mixer (1 piece) Solace India
Balance (1 piece) Mettler PE 600 Germany
Multi-mill (1 piece) Solace India
NR Cota machine
(1 piece)
N.R. Industries Germany
Compression Machine
(1 piece)
Jaguar India
Cap. Sealing machine
( 1 piece)
Marks (India) private limited India
29. SUPPLY CHAIN MANAGEMENT DEPARTMENT
It has the following five functional divisions:
1.Material Management
2.Procurement
3.Export
4.Ware house
5.Vat and customs
30. Production Planning
Product planning is an important department in Novartis
(Bangladesh) limited. They develop the planning for the operation of the
plant. There main objective is to prepare an upcoming 18 months plan
for manufacturing operation of the plant. This is reevaluated after every
one month. In this 18 months planning there aim is to meet the global
and local requirements by analyzing GROFO (Global Rolling
Forecasting Order) and ROFO (Rolling Forecasting Order).
By analyzing these data product planning department decides
the quantity of raw materials, HALB and PERT production. Here HALB
means semi finished product and PERT is the final product before
packaging. The word HALB and PERT are German words. Only Novartis
uses this two terms in the pharmaceutical sector in Bangladesh.
31. Warehouse
According to GMP a pharmaceutical Warehouse should have the facility of controlling
and maintaining of temperature and humidity as per the needs of the material stored.
At Novartis the warehouse maintains three different types of temperature zone depending
on products merit:
Cold - (2° C to 8° C)
Cool - (8°C to 20° C)
Room temperature (24° C ± 2° C)
Functions:
• Receiving in-voice and purchase order & materials
• Labeling & Documentation
• Storing materials in different room temperature based on product merit.
• Market analysis
• Production support
32. Health Safety And Environment (HSE) Department
To minimize the risk of hazard Novartis Bangladesh has a health, safety &
environment department. This provides the safety for both human and
wealth. Normally safety means, prevention from all unwanted or
unintentional harm.
Hazard means source of any kind of harm. Hazard can be,
Task associated hazard
Location related hazard
Material related hazard
Fatality
Accident Observation
Near Miss
Hazard Identification
33. Technical Service Department
Technical Service Department is a supportive service department in any pharmaceutical
industry, which exercises its activities and duties through maintenance and repairing of the
electrical and mechanical devices & other facilities of the industry. They provide all sorts of
engineering and technical supports in the industry whenever necessary.
Instruments used for the supply support :
Electricity
Generator
Compressed Air
HVAC system
Cold Water/Hot Water/Water Supply
Deionized water plant
Effluent Treatment Plant(ETP)
34. Admin & IR Department
Tools Used:
• Payroll
• Employee Relation & Welfare
• Planning/Counselling
Individual Functions:
• Stationary
• Transport facility
• Canteen
• Gardening
• Security
• Seating
• Laundry (In house)
• Accidental benefit